BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zak-Gołąb A, Olszanecka-Glinianowicz M, Kocełak P, Chudek J. [The role of gut microbiota in the pathogenesis of obesity]. Postepy Hig Med Dosw (Online) 2014;68:84-90. [PMID: 24491899 DOI: 10.5604/17322693.1086419] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Uchida D, Takaki A, Adachi T, Okada H. Beneficial and Paradoxical Roles of Anti-Oxidative Nutritional Support for Non-Alcoholic Fatty Liver Disease. Nutrients 2018;10:E977. [PMID: 30060482 DOI: 10.3390/nu10080977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Akhmedov VA, Gaus OV. Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2019;91:143-8. [DOI: 10.26442/00403660.2019.02.000051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ross MC, Muzny DM, McCormick JB, Gibbs RA, Fisher-Hoch SP, Petrosino JF. 16S gut community of the Cameron County Hispanic Cohort. Microbiome 2015;3:7. [PMID: 25763184 DOI: 10.1186/s40168-015-0072-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
4 Borrelli A, Bonelli P, Tuccillo FM, Goldfine ID, Evans JL, Buonaguro FM, Mancini A. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. Redox Biol 2018;15:467-79. [PMID: 29413959 DOI: 10.1016/j.redox.2018.01.009] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 27.0] [Reference Citation Analysis]
5 Jin D, Wu S, Zhang YG, Lu R, Xia Y, Dong H, Sun J. Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome. Clin Ther 2015;37:996-1009.e7. [PMID: 26046242 DOI: 10.1016/j.clinthera.2015.04.004] [Cited by in Crossref: 125] [Cited by in F6Publishing: 110] [Article Influence: 25.0] [Reference Citation Analysis]
6 Chakraborti CK. New-found link between microbiota and obesity. World J Gastrointest Pathophysiol 2015;6:110-9. [PMID: 26600968 DOI: 10.4291/wjgp.v6.i4.110] [Cited by in CrossRef: 156] [Cited by in F6Publishing: 140] [Article Influence: 26.0] [Reference Citation Analysis]
7 Kutlu O, Kaleli HN, Ozer E. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma. Can J Gastroenterol Hepatol 2018;2018:8543763. [PMID: 30228976 DOI: 10.1155/2018/8543763] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 10.7] [Reference Citation Analysis]
8 Yin X, Liao W, Li Q, Zhang H, Liu Z, Zheng X, Zheng L, Feng X. Interactions between resveratrol and gut microbiota affect the development of hepatic steatosis: A fecal microbiota transplantation study in high-fat diet mice. Journal of Functional Foods 2020;67:103883. [DOI: 10.1016/j.jff.2020.103883] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]